Article

New device allows non-surgical blepharoplasty

Non-surgical blepharoplasty can provide surgeons with a minimally invasive approach to eyelid procedures.

Key Points

Marlton, NJ-Non-surgical blepharoplasty can provide surgeons with a minimally invasive approach to eyelid procedures.

Using a blepharoplasty device (EyeTight, LaserTight LLC), which is FDA cleared for lower lid blepharoplasty, the procedure is performed using local anesthesia and can be completed within 15 minutes. There is minimal downtime for the patient, and skin tightening continues for 6 to 8 weeks after the procedure.

The device uses 980-nm laser energy delivered through a customized 20-gauge endoprobe to vaporize fat cells. Other similar procedures using LaserTight devices can be performed on other parts of the body. Demand for such procedures is expected to increase.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.